San Francisco Sentry Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$228K Sell
993
-75
-7% -$15.1K 0.12% 185
2021
Q1
$200K Hold
1,068
0.09% 225
2020
Q4
$181K Buy
1,068
+119
+13% +$17.8K 0.09% 216
2020
Q3
$141K Sell
949
-9
-0.9% -$1.39K 0.07% 225
2020
Q2
$157K Sell
958
-152
-14% -$23.3K 0.08% 206
2020
Q1
$154K Sell
1,110
-252
-19% -$34.6K 0.1% 182
2019
Q4
$179K Sell
1,362
-1
-0.1% -$116 0.08% 215
2019
Q3
$153K Sell
1,363
-12
-0.9% -$1.34K 0.07% 226
2019
Q2
$152K Sell
1,375
-211
-13% -$24.8K 0.07% 225
2019
Q1
$205K Sell
1,586
-492
-24% -$59.8K 0.09% 207
2018
Q4
$241K Buy
2,078
+17
+0.8% +$1.9K 0.11% 161
2018
Q3
$221K Sell
2,061
-18
-0.9% -$1.8K 0.08% 197
2018
Q2
$177K Sell
2,079
-407
-16% -$33.4K 0.07% 222
2018
Q1
$192K Sell
2,486
-154
-6% -$12.4K 0.06% 277
2017
Q4
$223K Buy
2,640
+100
+4% +$8.51K 0.07% 245
2017
Q3
$218K Buy
2,540
+964
+61% +$79.1K 0.07% 231
2017
Q2
$129K Buy
+1,576
New +$129K 0.05% 274
2014
Q4
Sell
-1,050
Closed -$68K 311
2014
Q3
$68K Sell
1,050
-438
-29% -$27.7K 0.03% 267
2014
Q2
$93K Sell
1,488
-124,950
-99% -$7.45M 0.04% 238
2014
Q1
$7.44M Buy
126,438
+351
+0.3% +$19.6K 2.39% 4
2013
Q4
$6.43M Hold
126,087
2.22% 6
2013
Q3
$6.35M Sell
126,087
-10,718
-8% -$561K 2.39% 6
2013
Q2
$6.72M Buy
+136,805
New +$7.44M 2.42% 6

Other funds holding LLY

San Francisco Sentry Investment Group's LLY Position: Q2 2021 in Review

San Francisco Sentry Investment Group reduced its Eli Lilly (LLY) stake by 7% in Q2 2021, selling an estimated $15.1K and leaving 993 shares worth $228K. The position accounts for 0.12% of the portfolio, ranked #185.

San Francisco Sentry Investment Group first reported a position in LLY in Q2 2013 and has held it in 23 quarters since. The position peaked at $7.44M in Q1 2014. 2,022 funds tracked by Wall St. Rank hold LLY as of Q2 2021.

  • San Francisco Sentry Investment Group held 993 shares of Eli Lilly worth $228K as of Q2 2021.
  • San Francisco Sentry Investment Group sold 75 Eli Lilly shares in Q2 2021, an estimated $15.1K.
  • Eli Lilly made up 0.12% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #185 holding.
  • San Francisco Sentry Investment Group first reported a position in Eli Lilly in Q2 2013 and has held it in 23 quarters since.
  • San Francisco Sentry Investment Group's Eli Lilly position peaked at $7.44M in Q1 2014.
  • 2,022 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.